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734Role of Echocardiography in Percutaneous Mitral Valve
Interventions
Intraprocedural imaging continues to evolve in parallel with advances in percutaneous mitral valve interventions. This didactic
reviewuses several illustrationsand rich intraprocedural videos to furtherdescribeanddemonstrate the roleof themostup-to-date
echocardiographic and advanced imaging technologies in the patient selection and intraprocedural guidance of percutaneous
mitral valve interventions. We will focus on 3 interventions: 1) percutaneous balloon mitral valvuloplasty for mitral stenosis; 2)
transcatheteredge-to-edgerepairofmitralvalve regurgitation;and3) transcatheterclosureofperiprostheticmitral regurgitation. In
addition, we discuss potential pitfalls of 3-dimensional transesophageal echocardiography and show examples of this
technique. (J AmColl Cardiol Img 2012;5:733–46) © 2012 by the American College of Cardiology Foundationtructural intervention procedures require
clear delineation of intracardiac anatomy,
which is currently not feasible with fluoros-
copy and cineangiography, without the ad-
dition of echocardiography, mostly using trans-
esophageal methods. The traditional strengths of
echocardiography (spatial and temporal resolution
and portability) have been supplemented by multi-
plane imaging and more recently the development
of simultaneous biplane imaging and real-time
3-dimensional imaging (RT3D), based on parallel
processing and faster computing technology. Al-
though an extensive review of the 3-dimensional
(3D) methodology is beyond the scope of this
paper, readers can benefit from 2 recent important
in-depth reviews (1,2).
This review will build on a worthy State-of-the-
Art Paper by Naqvi (3), published in iJACC a few
years ago, by further describing the role of the most
up-to-date echocardiographic methods (including
RT3D and simultaneous biplane transesophageal
echocardiography [TEE]) in patient selection and
intraprocedural monitoring of patients undergoing
percutaneous mitral valve interventions. We will
focus on 3 interventions: 1) percutaneous mitral
balloon valvuloplasty (PMBV) for mitral stenosis;
2) transcatheter edge-to-edge repair (TE2E) of
mitral valve regurgitation; and 3) transcatheter clo-
sure of periprosthetic regurgitation (TPPR).
PMBV for Mitral Stenosis
Patient selection. Since its introduction in 1984 by
Inoue et al. (4), PMBV has become a safe, effective,
less invasive alternative to surgery, with low com-plication rates, for some patients with symptomatic
rheumatic mitral stenosis. In properly selected pa-
tients, PMBV obtains excellent immediate and
sustained hemodynamic improvement, comparable
to the results of surgical procedures, including open
or closed mitral commissurotomy and mitral pros-
thetic replacement (5,6).
Proper patient selection is of major importance
when predicting the immediate and long-term re-
sults of PMBV. The most validated and commonly
used transthoracic echocardiographic (TTE) crite-
rion is the one originated by Wilkins et al. (7),
which we call the “splitability score.” This assess-
ment by TTE takes into account the severity and
extent of leaflet calcification, leaflet thickening,
leaflet mobility, and involvement of the subvalvular
apparatus (Table 1), each graded qualitatively on a
1-to-4 scale (maximum total score  16). An
inverse relationship exists between the total spl-
itability score and PMBV success, with the cutpoint
of 8 reflecting best short- and long-term results.
Of note, Wilkins score alone does not appear to be
a good predictor of post-PMBV mitral regurgita-
tion (MR), but rather the degree of commissural
opening (8,9). In addition, it is important to care-
fully quantify the severity of underlying MR before
percutaneous valvotomy (Online Video 1A and 1B,
Figs. 1A to 1C). MR that is 2 has been
demonstrated by Palacios et al. (9) to be associated
with worse outcome. Recent technological advances
such as RT3D echocardiography with multiplanar
reformatting have allowed more precise measure-
ment of the mitral valve (MV) area before the
procedure (Fig. 1D). 3D TEE allows interrogation
of the commissures more directly, which is very
helpful to understanding asymmetric fusion or cal-
cification of commissures. These asymmetric defor-
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735mations of mitral orifice may increase the risk of
MR with balloon valvuloplasty. Further, alteration
in shape of mitral orifice in 3D is the consequence
of subvalvular, valvular, and leaflet scarring, all of
which are important determinants for the success of
balloon valvuloplasty (10,11).
TEE before PMBV is useful to screen for left
atrial (LA) or LA appendage thrombus or dense
spontaneous echo contrast, which are common in
mitral stenosis patients, due to LA blood stasis and
atrial fibrillation.
A small single-center study of 23 patients evalu-
ated the role of multiphase cine cardiac computed
tomography (CT)–derived Wilkins score to predict
MV area changes after PMBV. Cardiac CT-
derived score was more predictive of MV area
increase after PMBV than echocardiographic-based
Wilkins score was. In particular, increased posterior
leaflet mobility, decreased leaflet thickness, and
absence of subvalvular disease were all associated
with MV area improvement following PMBV (12).
To this date, cardiac magnetic resonance imaging
has not been used in patient selection or procedural
guidance in PMBV.
Intraprocedural monitoring. After obtaining venous
nd arterial access, TEE is typically performed
nder conscious sedation in the catheterization
aboratory. Adequate anesthesia of the posterior
harynx and suctioning is the key to success for
atient comfort. Prior to septal puncture, the atrial
ppendage and LA are carefully assessed to rule out
hrombus. Thrombus can develop in the appendage
ery rapidly, especially when anticoagulation is
ithheld for the procedure. Reassessment of MR
nd gradients at this time can serve as an important
aseline to compare after balloon inflations to judge
dequacy of the procedure.
Although the transseptal puncture can be per-
ormed primarily by fluoroscopic guidance, ultra-
ound imaging with TEE or intracardiac echocar-
iography can be useful, improving visualization of
he contiguous structures and mainly avoiding aor-
ic puncture. The specific location of the transseptal
uncture may be customized to meet the needs of
he specific procedure. Crossing at the level of the
ossa ovalis in the posterior inferior part is best for
ost PMBV. The transseptal puncture site can be
hosen using the visualization by TEE of tenting
f the atrial septum by the catheter before ad-
ancing the needle. Figure 2 shows TEE guid-
nce, using multiple planes/views. For example,
he bicaval view secures the proper height,
hereas the proper distance from the aorta is best appreciated in the short-axis view. This becomes
articularly important in patients with previous
eptal surgeries or punctures, excessively mobile
eptum, and in patients with very large atria or
istorted anatomy as seen in patients with scoli-
sis or pneumonectomy.
Although fluoroscopy has an important role,
EE is very helpful to optimize balloon position
cross the MV leaflets and avoid entrapment in the
ubvalvular apparatus. TEE imaging with 2 simul-
aneous orthogonal planes is helpful to visualize the
est position for Inoue balloon placement between
he MV leaflets and guide during its quick inflation
Online Video 2A and 2B). TEE use is critical to
dentify and prevent complications such as pericar-
ial effusion and aortic puncture.
Immediately following PMBV, the TEE exam
hould be targeted to answer quickly 4
mportant questions:
. How severe is the MR and does it
emerge from a commissural location?
(Online Video 3A and 3B, Figs. 3A
and 3B)
. What are the post-PMBV MV area
and the peak/mean MV gradients?
(Figs. 3C and 3D)
. Is there good commissural opening? Is it
bilateral or unicommissural? (Fig. 3D)
. Is there any increase in pericardial effu-
sion? If so, what is the size, and what are
the hemodynamic consequences?
RT3D with multiplanar reformatting
mmediately after PMBV provides supe-
ior estimation of MV area compared
ith conventional TEE (Fig. 3D) (13).
ntraprocedural RT3D immediately after balloon in-
ation can diagnose the presence and extent of leaflet
ears better than TTE, 2-dimensional (2D) TEE, or
ntracardiac echocardiography can (14).
RT3D also provides improved ability to deter-
ine the degree of commissure opening after
MBV, which is an important prognosticator of
he clinical procedural success in addition to the
raditional measurement of MV area and gradi-
nts (15). Immediate post-procedure measure-
ents of valve area and gradients might obtain
ifferent results than measurements performed
ater after LA remodeling and changes in wall
ompliance. Furthermore, changes in heart rate
ay also have an impact on mitral gradients,
otentially misleading interpretation of compar-
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736TE2E Repair of MV Regurgitation
This percutaneous mitral clip technique mimics the
surgical mitral repair procedure introduced in 1991
by the Italian surgeon Ottavio Alfieri who success-
fully treated a patient with anterior leaflet prolapse.
Using a pledgeted stitch to approximate the edges
of the middle portions of the anterior and posterior
mitral valve leaflets, Alfieri created a double orifice
(“figure of 8”) (16). In the largest surgical series
ral Assessment of a Stenotic MV by TEE
chocardiography (TEE) at mid-esophageal level at 0° (“4-chamber
bileaﬂet thickening involving the mid-distal segments of the
reduced opening. (B) Simultaneous biplane imaging of the MV at
vel at 0° and 90° (right) with color Doppler showing mild mitral
t baseline. (C) Continuous-wave Doppler indicating increased
D) Real-time 3-dimensional imaging with multiplanar reformatting
notic MV with important commissural fusion (MVA  0.84 cm2).
scallop; LA  left atrium; LV  left ventricle; MVA  mitral valve
of MV Anatomy According to the Wilkins Score
Mobility Thickening
ile valve with only leaﬂet tips Leaﬂets near normal in thicknes
(4–5 mm)
and base portions have normal Mid-leaﬂets normal, considerab
thickening of margins
(5–8 mm)
ues to move forward in diastole,
om the base
Thickening extending through
the entire leaﬂet (5–8 mm)
al forward movement of the
diastole
Considerable thickening of all
leaﬂet tissue (8–10 mm)
is the sum of the 4 items and ranges between 4 and 16.terior scallop; PMBV  percutaneous mitral balloon valvuloplasty.from this same group, including 260 patients who
underwent such repair, 80% of the cohort had
additional MV annuloplasty that was associated
with reduced reoperation at a mean follow-up of 5
years (17).
TE2E implants a clip that grasps the free edges
of the middle portions of the MV, to reduce the
degree of MR. For example, a portion of 1 leaflet
that is prolapsing or flail can be supported by
attaching it via the clip to the opposite leaflet that
has intact chordae.
Several other devices designed to mimic a surgi-
cal annuloplasty are under development and/or
earlier stages of clinical trials. However, as docu-
mented by CT (18), the method of coronary sinus
implantation has some dangers of affecting the
circumflex artery and missing the desired annulus
location.
The MitraClip system (Evalve Inc., Menlo Park,
California) has been the most studied device cur-
rently available for transcatheter treatment of MR.
The EVEREST I (Endovascular Valve Edge-to-
Edge Repair Study) established the safety, feasibil-
ity, and hemodynamic improvements in patients
with moderate to severe (3) to severe (4) MR.
The morbidity and mortality were low, and the MR
was reduced to 2 in the majority of patients,
along with sustained freedom from death (19).
Recently, the results of the EVEREST II trial were
reported, which randomized patients with 3 to 4
MR to either percutaneous repair or surgical repair/
replacement. Percutaneous repair was less effective
at reducing MR than conventional surgery was
(approximately 23% patients were left with 3
MR), but the procedural risk of TE2E was low.
The surgical and the TE2E groups with successful
treatment showed similar improvements in reduc-
Calciﬁcation Subvalvular Thickening
A single area of increased
echo brightness
Minimal thickening just below
the mitral leaﬂets
Scattered areas of brightness
conﬁned to leaﬂet margins
Thickening of chordal
structures extending to
one-third of the chordal
length
Brightness extending into the
mid portions of the leaﬂets
Thickening extended to distal
third of the chords
Extensive brightness
throughout much of the
leaﬂet tissue
Extensive thickening and
shortening of all chordal
structures extending down
to the papillary musclesFigure 1. Pre-Procedu
(A) Transesophageal e
view”). Note moderate
mitral valve (MV) with
the mid-esophageal le
regurgitation (arrow) a
transmitral gradients. (
showing a severely ste
A2  middle anteriorTable 1. Assessment
Grade
1 Highly mob
restricted
s
2 Leaﬂet mid
mobility
le
3 Valve contin
mainly fr
4 No or minim
leaﬂets in
The total Wilkins score (3)tion in LV size as assessed by echocardiography and
m
t
p
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737similar clinical improvement in symptoms and ex-
ercise capacity (20). The high-risk registry data
recently showed improvement in MR in a majority
of patients, resulting in improvement in clinical
Figure 2. Transseptal Puncture Under TEE Guidance
Note tenting of the fossa ovalis by the catheter before advancing
the needle. RA  right atrium; other abbreviations as in Figure 1.
Figure 3. Post-PMBV Assessment of the MV by TEE
(A) Post-PMBV TEE, from the same patient illustrated in Figure 1, show
is observed after PMBV with integrity of the mitral leaﬂets and subvalv
niﬁcant improvement of transmitral gradients. (D) Post-PMBV real-time
improvement in the MVA (from 0.84 to 1.74 cm2), and commissural op
differences before and after PMBV with Figure 1D. MR  mitral regurgitatisymptoms and significant left ventricular reverse
remodeling over 12 months (21).
Patient selection. TE2E has been successful in re-
ducing MR in 2 groups of patients: those with
excessive leaflet motion (myxomatous degeneration
with prolapse or flail); or those with functional MR
(apical tethering of normal leaflets), including pa-
tients with left ventricular enlargement from isch-
emic heart disease. TE2E is not applicable to
patients with MR due to restricted leaflet motion
(rheumatic MR) and those with flail or prolapse
that does not involve the middle portion of the
anterior or posterior mitral leaflets, the “grasping
area” for the TE2E procedure, or in whom that area
is calcified (22).
A key TTE inclusion criterion for the MitraClip
requires a regurgitant jet origin associated with the
A2 to P2 segments of the MV and not at the commis-
sures. For patients with functional MR, the coapta-
tion length must be at least 2 mm, and the coaptation
depth less than 11 mm. For patients with flail leaflet,
the flail gap must be 10 mm and the flail width 15
m (19) (Fig. 4). Calcification of the grasping area of
he leaflets is also a contraindication because of
otential risk of embolization. A critical goal of the
proved mobility of both MV leaﬂets (still diastolic frame). (B) Mild MR
apparatus. (C) Continuous-wave Doppler across the MV reveals sig-
imensional imaging with multiplanar reformatting shows signiﬁcant
g (arrows) making planimetry a less valid parameter. Compare MVAs im
ular
3-d
eninon; other abbreviations as in Figure 1.
Edge-to-Ed
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738pre-procedural echo imaging study is the determi-
nation of the MR mechanism and severity (Online
Video 4A and 4B, Figs. 5A to 5D). Which leaflet is
Anatomic Eligibility Criteria for MitraClip (EVEREST Trial)
tional MR, the primary mechanisms are mitral annular dilation
restriction secondary to LV remodeling. The posterior mitral leaf-
commonly involved from scarring of the inferior wall and pos-
l papillary muscle. These processes lead to apical tethering with
tion of the MV leaﬂets as shown. The coaptation length must be
m, and coaptation depth must be 11 mm so that there is
e the clip can grasp. (B) In degenerative MR with MV prolapse
l, measurements such as ﬂail depth 11 mm and a ﬂail width on
15 mm are important anatomic features associated with
MitraClip procedural success. EVEREST  Endovascular Valve
ge Repair Study; other abbreviations as in Figures 1 and 3.
Figure 5. TEE Assessment of MV Morphology, Regurgitation Me
(A) Two-dimensional TEE at mid-esophageal level 0° using real-time
MV annular dilation and leaﬂet tethering leading to central malcoa
at 95° of the MV with color Doppler showing systolic frame represe
convergence zone with large radius (1.0 cm). (C) Pulse-wave Doppl
marked systolic blunting (S) indicative of elevated LA pressures. (D)
dense holosystolic regurgitant jet with high peak velocity. All these feamoving abnormally is determined using long-axis
views. Which portion of the leaflet is moving
abnormally is determined from 2D short-axis views,
2D intercommissural long-axis views, or RT3D;
this has improved the complete visualization of MV
scallops (23,24) (Online Video 5, Fig. 6).
The potential role of cardiac CT (25,26) and
cardiac magnetic resonance (25) in the assessment
of a patient’s eligibility and intraprocedural guid-
ance for percutaneous MV procedures has been
reviewed elsewhere (25). The feasibility and true
clinical utility of these techniques remain untested
in a large-scale cohort of patients.
Another important goal of the pre-procedural
echo is to quantitate carefully the severity of MR
using American Society of Echocardiography
guidelines. For this, important images are zoom
mid-esophageal long-axis or 4-chamber views of
the flow convergence, for measurement of the
aliasing radius (to calculate regurgitant orifice area)
and the diameter of the vena contracta, although for
MR jets that are eccentric, not holosystolic, or have
proximal constraint, the assumptions of these
calculations may be misleading. Additional useful
views include a pulsed Doppler assessment of the
nism, and Quantiﬁcation
lane imaging with orthogonal planes showing functional MR with
ion between A2 and P2 scallops. (B) Mid-esophageal zoomed view
g severe central mitral regurgitation jet. Note the proximal ﬂow
terrogation of the right upper pulmonary vein ﬂow showing
tinuous-wave Doppler through the MV, which demonstrates aFigure 4.
(A) In func
and leaﬂet
let is more
teromedia
malcoapta
at least 2 m
some tissu
and/or ﬂai
short axis
increasedcha
bip
ptat
ntin
er in
Contures are consistent with severe MR. Abbreviations as in Figure 1.
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739pattern of systolic reversal of flow in 1 or more
pulmonary veins (Fig. 5C) and the density of
continuous wave Doppler recordings through the
mitral orifice (Fig. 5D). These assessments pro-
vide an important baseline for comparison after re-
pair, although the flow convergence methods are very
difficult or nearly impossible once the MitraClip is in
place, mostly due to the multiplicity of residual regur-
gitant jets after clip deployment.
Intraprocedural monitoring. The success in delivering
the MitraClip under real-time echocardiographic guid-
Figure 6. RT3D TEE With En Face View of the MV (Systolic Fram
Marked myxomatous changes of the MV leaﬂets, with particularly s
area (ROA) created by the malcoaptation of the prolapse scallops (D
adding detailed information about the anatomy of MV scallops and
aortic valve (AV) is, and the left atrial appendage (LAA) is to the lef
other abbreviations as in Figure 1.
Table 2. Role of Transesophageal Echocardiography in
Edge-to-Edge MV Repair Technique (MitraClip)
Assessing the mechanism of MR
Quantitating the severity of MR
Guiding transseptal crossing
Aligning the delivery system perpendicular to the mitral plane
at the location of the MR jet
Alignment of clip’s arms perpendicular to MV coaptation line
Determining success of grasping both leaﬂets
Veriﬁcation of clip stability after release from delivery system
Reassessing MR severity
Locating of persistent leak(s)MR  mitral regurgitation; MV  mitral valve.ance is a result of the unique collaboration between
interventionalists and echocardiographers. The TE2E
procedure entails a standard sequence of maneuvers,
all of which are monitored and guided by echocardi-
ography (Table 2).
e P2 prolapse and mild A2 prolapse. Note the regurgitant oriﬁce
ost-processing software allows multiplanar reconstruction (B,C,E,F)
tionship with other structures. Anterior is to the top, where the
the ﬁgure. RT3D  real-time 3-dimensional; SAX  short axis;
Figure 7. TEE Bicaval View With Simultaneous Biplane
Imaging Showing IAS Dilation by the Guiding Sheath
Arrows indicate the interatrial septum (IAS) dilation by the guid-
ing sheath. SVC  superior vena cava; other abbreviations as ine)
ever
). P
rela
t ofFigures 1 and 2.
as in Figur
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740Supervision of transseptal puncture and crossing
is the first goal of TEE imaging. As mentioned
before, TEE or intracardiac echocardiography can
visualize the location where the catheter indents the
atrial septum, allowing the interventionalist to ad-
just the location of septal crossing, aiming far
enough superiorly and posteriorly to allow the arc of
the catheter to easily reach the middle of the mitral
orifice. A mid-esophageal aortic valve short-axis
TEE at Mid-Esophageal Level With Simultaneous Biplane
howing the Guide Sheath Transversing the Interatrial Septum
he LA
sheath (arrow) into the LA at a safe superior distance from the
ibicaval view showing the guide sheath tip pointing away from
lls. (C) Live 3-dimensional (3D) view from the LA perspective, look-
the RA. (D) Components of the MitraClip shown by 3D echo:
th, delivery catheter, and MitraClip at the distal tip. Abbreviations
es 1, 2, 6, and 7.
Figure 9. Advancing the MitraClip Into the LV
(A) RT3D of the mitral valve in the en face/surgeon’s view using pr
view using simultaneous biplane imaging showing the MitraClip be
the correct position where the MR jet is. Although the image frame
it intermittently to aid in the ﬂuoroscopic guidance for the interventionview (multiplane angle of approximately 30° to 60°)
and the bicaval view at 90° to 100° are useful during
the transseptal puncture to visualize all the adjacent
structures avoiding device-endocardial contact. The
transverse 4-chamber (0°) imaging plane can assess
the height of proposed septal puncture above the
valve plane (22).
Once the interatrial septum is crossed, the next
step is to dilate the interatrial septum to allow the
passage of the delivery system and clip toward the
regurgitant MV (Fig. 7). During advancement of
the super stiff wire, monitoring with TEE can help
to avoid puncture of the LA appendage or LA wall
to avoid pericardial tamponade. The catheter tip is
echodense and should be imaged during most
manipulations to avoid contact with the posterior
and lateral structures such as the lateral LA wall and
LA appendage (Online Video 6, Fig. 8). Then the
delivery catheter is turned inferiorly and aligned
parallel to the antegrade mitral flow. For this, the en
face RT3D of the MV “surgeon’s view” from the
LA perspective (23) (Fig. 9A) is helpful. We
particularly use the biplane real-time imaging with
1 plane in the intercommissural orientation (at
multiplane angles of about 45° to 70°), and the
other in a long-axis orientation (Fig. 9B). The clip
should be positioned where the largest mitral re-
gurgitant jet is located by color Doppler mapping,
such that it splits the jet and is pointed parallel to
the direction of mitral antegrade flow (Online
Video 7).
Once the tip of the delivery catheter is poised in
the LA just above the MV, the arms of the clip
device are then opened. It is important to rotate the
perpendicular alignment of the MitraClip. (B) Mid-esophageal
advanced into the MV. Color Doppler mapping is used to guide
e decreases due to increased processing demand, we tend to useFigure 8.
Imaging S
and Into t
(A) Guide
AV. (B) Sem
the LA wa
ing toward
guide sheaoper
ing
ratal cardiologist. Abbreviations as in Figures 1, 3, and 6.
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741clip arms so that they are perpendicular to the
mitral coaptation line, primarily using the RT3D
surgeon’s view; when it is unavailable, the transgas-
tric 2D short-axis view of the MV should be used,
although it is difficult to obtain in about one-third
of patients (Online Video 8, Figs. 10A and 10B).
After passage of the clip into the left ventricle,
and final verification of its position and orientation,
the open device is pulled up to grasp the leaflets
from their underside. Both RT3D and simultane-
ous biplane imaging are crucial at this point to
determine the success of grasping both leaflets
(Figs. 11A and 11B). Once both leaflets are
grasped, the arms of the clip are closed and an
assessment is made of the new severity of the MR
(Online Video 9, Fig. 11C). If the MR has not been
substantially reduced, the clip is everted and
brought back into the LA, and a repeat placement
of the same clip is attempted. If the MR has been
substantially reduced, the clip arms are tightened
and the delivery system is detached. After verifica-
tion of the stability of the clip, the suture attached
to the clip is pulled through to remove the final
tether of the clip (Online Video 10, Fig. 11D).
Finally, repeat assessment of the severity of the
residual MR and the mitral gradient, before and
during afterload manipulation with phenyleph-
rine, helps to determine whether a second clip
should be placed, which is indicated usually if
moderate or greater (2) MR is present. If
needed, the second clip should be positioned
where the flow convergence and vena contracta
are largest. Before a second clip is deployed, it is
important to search for any significant increase in
transmitral gradients resulting from the first clip.
This routine practice is probably the explanation
why no cases have been reported of acute mitral
stenosis with this procedure. Finally, in patients
with hypotension, it may be useful to manipulate
afterload and pre-load to evaluate the severity of
MR under hemodynamics more comparable to
ambulatory conditions.
This TE2E procedure can be lengthy and very
demanding on both the echocardiographer and
interventionalist. Both RT3D and simultaneous
biplane imaging provide substantial value over
single-plane 2D TEE by reducing the need to flip
the image back and forth between the intercom-
missural and long-axis views. Frequent monitor-
ing of the pericardial space allows early detection
of growing effusions before hemodynamic com-
promise develops. As mentioned previously, good
communication between the echocardiographerand the interventionalist, using standardized vo-
cabulary and anatomical landmarks, is essential to
decrease maneuvering error and to increase pro-
cedural efficiency. With the advent of 3D echo-
cardiography, there is also a need for proper
training of the interventional cardiologist on the
basic 3D views. This is of critical importance if
Figure 10. Transgastric View With Retroﬂexion Showing the LV
Short-Axis View With the MitraClip Straddling the MV Leaﬂets
(A) Note that the MitraClip (arrow) is not orientated perpendicular
MV coaptation line (dashed blue line). (B) MitraClip position is corr
with 30° of clockwise rotation of the delivery catheter. Lat  latera
medial; other abbreviations as in Figure 1.
Figure 11. Sequence of Events in the Deployment of Edge-to-Ed
Repair Technique (MitraClip)
(A) Simultaneous biplane imaging at 60° and 150° demonstrates th
location of the MitraClip within the MV structure. Once the position
ﬁrmed, grasping of the MV leaﬂet occurs. (B) Live 3D zoomed view
delivery catheter and MitraClip grasping the A2 and P2 scallops of
(C) Similar to A, simultaneous biplane imaging at 60° and 150° dem
strates trivial to mild (1) MR after MitraClip grasps the MV leaﬂets
MitraClip system is ﬁnally released from the delivery system and se
(arrow) in the center of the new “ﬁgure-of-8” MV. Ant  anterior; Pin
to the
ected
l; Med ge MV
e exact
is con-
of the
the MV.
on-
. (D)
en
ost posterior; other abbreviations as in Figures 1, 3, 8, and 10.
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742this technique is used for real-time navigation.
Orientation in the 3D domain can be particularly
confusing the absence of internal anatomical
landmarks. A recent document from the Euro-
pean Association of Echocardiography and the
American Society of Echocardiography provides
an important practical guide on the image acqui-
sition, interpretation, as well as current and
potential clinical applications of 3D echocardiog-
raphy (2).
. TEE Baseline Assessment of ParaVR
imensional (2D) TEE at mid-esophageal 4-chamber view (0°)
aravalvular regurgitation (ParaVR) (arrow) outside the anterior
the MV bioprosthesis annulus. Also note the ﬂow convergence
whead), which suggests signiﬁcant regurgitant ﬂow. (B) At
n from another angle, is the severe anterior paravalvular leak
) RT3D of the MV bioprosthesis demonstrating the paravalvu-
rrow). Note the AV is on the top. (D) RT3D with color Doppler
large anterior paravalvular leak (arrow). Abbreviations as in
Table 3. Role of TEE in TPPR
Assessing the severity of ParaVR
Identiﬁcation of the location and number of holes
Guiding atrial septal puncture or LV apical puncture (in patients
with the combination of prosthetic aortic and mitral valves or
issues of crossing the aortic valve)
Guiding placement of the veno-arterial rail
Assessing reduction in ParaVR during balloon inﬂation
Assisting with placing the disk in the defect
Monitoring the effects of the device on prosthetic leaﬂet
(occluder) motion
Reassessing the severity of ParaVR
LV  left ventricular; ParaVR  paravalvular regurgitation; TEE  transesoph-
ageal echocardiography; TPPR  transcatheter closure of periprosthetic
regurgitation.f
6, and 11.TPPR
Patient and device selection. Paravalvular regurgita-
tion (ParaVR) is common, but most cases are small
and asymptomatic. Clinically important ones, oc-
curring in as many as 5% of patients who have
undergone valve replacement, tend to present with
congestive heart failure, hemolytic anemia, or ar-
rhythmias. This may result from suture dehiscence
due to infection (endocarditis), annular calcifica-
tion, technical problems, and/or a combination of
all of those.
Surgical intervention is usually recommended to
patients with symptomatic ParaVR, especially if it is
associated with infection, although increased mor-
bidity and mortality associated with reoperation
have stimulated the development of other options
to address this complex problem. TPPR appears as
an attractive, albeit challenging, alternative. Most
published evidence comes from single-center expe-
rience with case reports predominantly involving
ParaVR of the MV prosthesis. More recently,
technical success has ranged from 63% to 100%
(27–30). In this new field of work, the design of
specific “plugging” devices is in its early phase (31).
Most reports of TPPR have entailed off-label use of
devices designed to close congenital septal defects
or vascular plugs.
Goals of imaging in TPPR and description of the
procedure. Transprocedural echocardiographic im-
ging in TPPR is critically important because it can
elp the interventionalist to: 1) locate the optimal
egion for transseptal puncture; 2) guide the cross-
ng of the hole that leads to ParaVR; 3) monitor the
ecrease in ParaVR during balloon inflation;
) monitor the onset of possible complications
pericardial effusion, iatrogenic post-procedure
trial septal defect or prosthetic leaflet entrapment);
nd 5) assess the final result of the device implan-
ation. Table 3 summarizes the important aspects of
EE for this particular procedure.
The role of transesophageal echo in TPPR be-
ins with assessing the severity of the ParaVR. This
s difficult in mitral ParaVR because the left ven-
ricular side of the mitral prosthesis, where the flow
onvergence would ideally be measured, is com-
only shadowed by the prosthesis itself. The pres-
nce of a mitral prosthesis also shields the left
entricular outflow tract where the periprosthetic
ortic regurgitation would be observed. Further-
ore, wall constraint often prevents the flow
onvergence from forming hemispheric isovelocityFigure 12
(A) Two-d
showing p
aspect of
zone (arro
150°, show
(arrow). (C
lar hole (a
shows theorms, so quantitation of the MR is often difficult.
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743Probably the most important role of TEE in
TPPR is identification of the location and number
of holes that are present. Single-plane and biplane
2D TEE with color Doppler imaging is the main-
stay tool for this purpose (Figs. 12A and 12B). Use
of RT3D with color Doppler imaging appears to be
useful (27,32,33) (Figs. 12C and 12D), although
low temporal resolution, lack of standardized an-
gles, and potential motion creating “stitching arti-
facts” are current limitations of this imaging tech-
nique. Nonetheless, for mitral prosthetic regurgitation,
the RT3D TEE with en face/surgeon’s view from
the LA is most helpful. Although necessitating
another step, the best convention should be to
rotate the image so the aortic valve is at the top of
the image (Figs. 11D and 12C). Multiple simulta-
neous biplane 2D views also are useful for charac-
terization of anatomic relationships. Note should be
made of which TEE imaging plane/angle best
visualizes the regurgitant jet.
We also frequently use a fluoroscopic overlay
technique with CT scanning produced by rotating
the C-arm at high speed around the patient (Syngo
DynaCT Cardiac, Siemens, Erlangen, Germany).
Several hundred images are acquired and recon-
structed as 3D volumes. Anatomic details of inter-
est are marked on the pre-procedural CT angiog-
raphy, which is coregistered to an intraprocedural
CT acquired in the catheterization laboratory.
The CT-CT registration is then fused to the
real-time fluoroscopic image, allowing better pro-
cedural navigation with fluoroscopy and with less
use of a contrast medium (34). Furthermore,
Figure 13. Fusion/Overlay of the ParaVR Information by TEE Wi
Rotating the C-Arm at High Speed Around the Patient
This technique allows better procedural navigation with ﬂuoroscop
tionist drawings indicating the site of transseptal puncture (1), the
ParaVR (blue circles) (not well-seen in this projection but correspo
(CT)/ﬂuoroscopy imaging overlay demonstrating the prosthetic M
according to appropriate en face TEE. Abbreviations as in Figures 1,guidance in the optimum site for transseptal
puncture (Fig. 13A) and overlaying the ParaVR
location, defined by TEE, on the fluoroscopy are
other important strengths of this new imaging
technique (Fig. 13B).
Access to the defect may be either antegrade via
a venous transseptal approach or retrograde in the
direction of the regurgitation from arterial access
(coming across the aortic valve or transapical). The
site of transseptal puncture in TPPR is highly
variable and dependent on the location of the
ParaVR. For example, lateral defects are better
approached with transseptal access in the posterior
part of the fossa via the inferior vena cava, whereas
medial defects adjacent to the septum require even
lower and posterior puncture (35). Therefore, im-
aging guidance of atrial septal puncture either by
intracardiac or TEE or with the CT/fluoroscopy
overlay as aforementioned is important in TPPR.
The objective is to pass a wire through from the
right atrium to the LA. The venous wire is then
snared using another wire introduced through the
femoral artery. In patients who have both aortic and
mitral valve replacements in place, the echo can
help guide LV apical puncture for downstream
access (27). The first (venous) wire is pulled
through and its tip exteriorized, which can thus
be called a veno-arterial rail (36). This allows
better support for the delivery catheter in situa-
tions where numerous defects and/or acute angles
are encountered thereby making transit of the
delivery catheter difficult across the ParaVR or
creating excessive kinking on it. Hence, TEE has
luoroscopic Overlay Technique With CT Scanning Produced by
) Fluoroscopic right anterior oblique projection with the interven-
thetic MV (2), aortic valve (“t3-leaf-clover”) (3), and the 2 sites of
ng to the sites on the next panel). (B) Computed tomography
nd the 2 sites of ParaVR (pentagon and square shapes)th F
y. (A
pros
ndi
V a6, and 12.
al MV leaﬂet functioning. Abbreviations as in Figures 1, 6, 8, and 12.
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744an important role in guiding placement of the
wire. Once the wire is in place, the intervention-
alist can move and approach placement of the
occluder device from either direction. Some op-
erators use balloon inflation within the defect
with TEE to see if the regurgitation is reduced by
this temporary occlusion of the defect. If balloon
occlusion reduces the regurgitation substantially,
TEE guides placement of the occluder device
within the defect. After the device is expanded,
TEE monitors for changes in the motion of
mechanical disks or other adverse effects on the
heart (Online Video 11, Fig. 14).
Reassessment of the ParaVR severity by TEE
enables a decision whether a second occluder device
is needed. This reassessment of the severity of
regurgitation again is problematic because often
there are unusual anatomy and perivalvular tracts
that are eccentric and shielded by a prosthetic valve
and the interventional device. Therefore, assess-
ment of the aliasing radius for calculation of the
regurgitant orifice area is problematic; other means
Figure 14. Percutaneous Closure of ParaVR From a Dehisced M
(A) There are 2 separate ParaVR jets (anterior and lateral) that are m
dehiscence. (B) Under ﬂuoroscopic and TEE guidance, transseptal p
deployment of ﬁrst Amplatzer device (St. Jude Medical, St. Paul, Mi
moderate residual anterior ParaVR. (D) The anterior ParaVR is now a
Once position is conﬁrmed, transient balloon inﬂation within the Pa
ParaVR) for subsequent deployment of the second Amplatzer devic
devices in close proximity to each other and, more important, normitral Bioprosthesis
oderate (2 to 3) in severity and arising from the area of annular
uncture allows the venous wire to cross the lateral defect. (C) Post-
nnesota). Note resolution of lateral ParaVR and close proximity of
pproached with the venous wire crossing of the ParaVR defect. (E)
raVR defect allows conﬁrmation of adequate position (no signiﬁcant
e. (F) Live 3D view of the mitral bioprosthesis shows the 2 Amplatzerof regurgitation assessment, including spatial colorFigure 15. Post-Procedural Complication in a Patient Who
Underwent TPPR and RT3D Artifacts
Aside from the iatrogenic atrial septal defect created (arrow), also note
2 common artifacts seen with the use of 3D TEE: 1) “stitch” artifact due
to irregular cardiac rhythm, probe, and/or patient (respiratory) move-
ments during the image acquisition, creating clear artiﬁcial lines that
divide/fragment the structure being imaged; and 2) near-ﬁeld artifact
due to improperly high gain-settings in the near ﬁeld creating a “dark
zone” over the area of interest. SBP  systolic blood pressure; TPPR 
transcatheter closure of periprosthetic regurgitation; other abbrevia-
tions as in Figures 1, 6, 7, and 8.
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745Doppler mapping and pulmonary vein flow profiles,
are required.
In summary, TEE is useful in guiding transcath-
eter closure of ParaVR by guiding access to the area
from the arterial and venous side, placement of the
occluder device, and assessment of the amount of
reduction of regurgitation.
Future Directions
Intraprocedural imaging (RT3D TEE, biplane im-
aging, CT/fluoroscopy overlay, etc.) will continue
to evolve in parallel with advances in percutaneous
MV interventions. In terms of TE2E, better patient
selection along with further refinements on the
device technology addressing the annulus compo-
nent in addition to the leaflet problem would be
crucial for the long-term success. In TPPR, better
design with low-profile devices could avoid compli-
cations such as inflow/outflow obstruction or leaflet
impingement.
Although 3D TEE is a powerful tool with several
advantages for use in percutaneous interventions,
improvements, in particular, the frame rate when
using simultaneous RT3D with color Doppler are
needed. Furthermore, during acquisition of full
volume 3D dataset, stitch artifacts can occur due to
irregular heart rhythm, patient’s respiratory motion,
or fine probe movements, making interpretationcompared with open surgical commis- plasty variables thwith device shadowing can also reduce the quality
of both 2D and 3D TEE, creating dropout or
near-field artifacts and potentially leading to incor-
rect diagnosis (Online Video 12, Fig. 15). For these
percutaneous procedures, we more frequently use
the live 3D option.
Finally, an experienced team composed by an
interventional cardiologist, an interventional echo-
cardiographer, a cardiothoracic surgeon, a cardiac
anesthesiologist, and nurses that are able to perform
both catheterization lab and operating room duties
is needed. Due to the overlap of domains of
knowledge, it is key that all parties, in particular the
echocardiologist and interventionalist, use not only
the same vocabulary, but also share crossed training
skills (e.g., training of the interventionalist on basic
echocardiographic views critical for the procedure,
and possession of unique interventional imaging
skill by the echocardiologist) (3,37).
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